Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

5.60
+0.12002.19%
Post-market: 5.600.00000.00%19:59 EDT
Volume:1.49M
Turnover:8.23M
Market Cap:629.89M
PE:-1.19
High:5.63
Open:5.30
Low:5.29
Close:5.48
52wk High:12.03
52wk Low:2.10
Shares:112.48M
Float Shares:93.95M
Volume Ratio:0.56
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7089
EPS(LYR):-5.0732
ROE:-65.11%
ROA:-0.45%
PB:1.59
PE(LYR):-1.10

Loading ...

Evolent Health executives to present at Cowen Annual Healthcare Conference and Oppenheimer Healthcare MedTech and Services Conference

Reuters
·
Feb 27

Evolent Health (EVH) Gets a Buy from Stephens

TIPRANKS
·
Feb 26

Truist Cuts Price Target on Evolent Health to $6 From $10, Keeps Buy Rating

MT Newswires Live
·
Feb 26

Evolent Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Feb 26

Evolent Health Q4 Loss Of US$3.84 Per Share Tests Bullish Margin Turnaround Narrative

Simply Wall St.
·
Feb 26

Evolent Health price target lowered to $6 from $10 at Truist

TIPRANKS
·
Feb 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evolent Health (EVH), Medtronic (MDT) and Cytokinetics (CYTK)

TIPRANKS
·
Feb 25

Evolent Health price target lowered to $4 from $9 at Canaccord

TIPRANKS
·
Feb 25

Evolent Health: Conservative Guidance and Elevated Reserves Set the Stage for 2026 Margin Upside and Support a Buy Rating

TIPRANKS
·
Feb 25

Evolent Health Cut to Sector Weight From Overweight by Keybanc

Dow Jones
·
Feb 25

KeyBanc Downgrades Evolent Health to Sector Weight From Overweight

MT Newswires Live
·
Feb 25

Evolent Health Inc : Keybanc Cuts to Sector Weight From Overweight

THOMSON REUTERS
·
Feb 25

Evolent Health Is Maintained at Buy by BTIG

Dow Jones
·
Feb 25

KeyBanc downgrades Evolent Health (EVH) to a Hold

TIPRANKS
·
Feb 25

Evolent Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 25

Evolent Health Q4 revenue slightly misses analyst expectations

Reuters
·
Feb 25

Evolent posts Q4 net loss attributable to common shareholders of USD 429.1 million (91.6%)

Reuters
·
Feb 25

Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B

TIPRANKS
·
Feb 25

BRIEF-Evolent Health Q4 Revenue USD 468.719 Million Vs. IBES Estimate USD 468.8 Million

Reuters
·
Feb 25

Evolent Health Q4 Revenue USD 468.719 Million VS. Ibes Estimate USD 468.8 Million

THOMSON REUTERS
·
Feb 25